Lausanne, Switzerland, November 28 , 2001 - Debiotech, S.A., a privately held Swiss medical device company, reveals today the name of its Japanese partner with whom it has entered into a long term agreement for its IV Expres^TM infusion pump in Japan.

Under this Agreement, the leading Japanese company JMS Corporation acquired exclusive rights to manufacture and market an IV pump system and related disposable cassette from Debiotech, which provide safe and cost-effective IV multi-mode therapy in both alternate site and home care settings in Japan. The agreement is based on upfront payment and royalties to Debiotech.

The IV Expres^TM Pump system developed by Debiotech, together with its unique patented disposable cassette, provides easy to use and accurate administration of intravenous fluids in every condition of use. Its small size and light weight as well as Telemedicine remote programming capability, with voice over data telephone transmission, represents a significant improvement in IV Therapy offering.

The IV Expres^TM Pump system is part of Debiotech's advanced drug delivery systems designed to meet the growing market need for improved administration systems, particularly in areas such as the home care environment, alternate site, and for oncology, patient analgesia or pediatric use.

JMS Corporation plans to market the IV Expres^TM Pump system and its disposable cassette in Japan under its brand name, using the already available manufacturing partners selected by Debiotech.

Dr. Frédéric Neftel, CEO, Debiotech, stated, "This Agreement is the result of a long term relationship and we are today delighted to combine our efforts towards improving the quality of life of patients in the field of IV therapy. This collaboration will also create a strong market presence for one of our leading products in Asia and contribute to our objective of global success. JMS, who has built a strong reputation for the quality of his products and enjoys a dominant market presence is, with no doubt, in the best position to market and sell our IV Expres^TM Pump system in Japan."

Dr. Hajime Kimura, President, JMS, stated, "We, both parties have built a new cooperation throughout R&D, Manufacturing and Marketing over IV therapeutic infusion devices after scrutinizing every related facet of both parties with a charter of entrepreneurial sprit and continuous improvement.The system effectively contributes to the fundamentals of our infusion device technology which consists of a product portfolio encompassing both intensive care and home healthcare.This is also an unwavering step to reinforce our outstanding IV device technology."

ABOUT DEBIOTECH

Debiotech S.A. specializes in the research and development of innovative medical devices in the field of IV and nutrition therapy, electronic infusion systems, drug reconstitution and syringes, flow control, dialysis, diagnostics, implantable drug delivery systems and micro-systems for insulin and peptide drug delivery. http://www.debiotech.com.

ABOUT JMS Corporation

JMS Corporation was established in 1965 and is Japan's second-largest producer of disposable medical supplies.
JMS Group employees over 2,000 in Asia, with 8 manufacturing plants and over 350 sales representatives.

Head Office: 3-10-6 Hachobori, chuo-ku, Tokyo
President: Dr. Hajime Kimura
Web site: http://www.jms.cc

Paid-in Capital: 5.6 billions of yen (End of March, 2001)
Consolidated Net Sales: 36 billions of yen (End of March, 2001)
Main Business: Manufacture and Sales of medical products, ex. I.V. solution, blood bags, disposable medical devices, dialysis systems, medical electronic products and home medical instruments, etc.